20357-20-4

Basic information

• Product Name: 2-NITRO 5-BROMO-BENZALDEHYDE
• Synonyms: 2-NITRO 5-BROMO-BENZALDEHYDE;5-BROMO-2-NITRO-BENZALDEHYDE;CU48750000;Benzaldehyde, 5-broMo-2-nitro-
• CAS NO: 20357-20-4
• Molecular Formula: C₇H₄BrNO₃
• Molecular Weight: 230.02
• Mol File: 20357-20-4.mol
• Article Data: 34

Chemical Properties

• Melting Point: 71.0 to 75.0 °C
• Boiling Point: 330.5 °C at 760 mmHg
• Flash Point: 153.7 °C
• Appearance: /
• Density: 1.781 g/cm³
• Vapor Pressure: 0.000166mmHg at 25°C
• Refractive Index: 1.652
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• Solubility: soluble in Methanol
• CAS DataBase Reference: 2-NITRO 5-BROMO-BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-NITRO 5-BROMO-BENZALDEHYDE(20357-20-4)
• EPA Substance Registry System: 2-NITRO 5-BROMO-BENZALDEHYDE(20357-20-4)

Safety Data

• Statements: 43
• Safety Statements: 36/37
• RTECS: CU4875000
• Hazardous Substances Data: 20357-20-4(Hazardous Substances Data)

Usage

General Description

2-Nitro 5-Bromo-Benzaldehyde is a chemical compound with the molecular formula C7H4BrNO3. It is a yellow solid with the chemical structure of a benzene ring substituted with a nitro and bromo group and an aldehyde functional group. 2-NITRO 5-BROMO-BENZALDEHYDE is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also used in the production of dyes and pigments. 2-Nitro 5-Bromo-Benzaldehyde has been found to have antibacterial and antifungal properties, and it has potential applications in the development of new drugs for the treatment of various diseases. However, it is important to handle and use this compound with caution, as it can be hazardous if not properly managed.

InChI:InChI=1/C7H4BrNO3/c8-6-1-2-7(9(11)12)5(3-6)4-10/h1-4H

Upstream product

• 552-89-6 2-nitro-benzaldehyde 
• 3132-99-8 m-bromobenzoic aldehyde 
• 105205-48-9 [(E)-2-(5-bromo-2-nitro-phenyl)-vinyl]-dimethyl-amine 
• 51686-78-3 2,4-dibromonitrobenzene 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 20357-31-7 5-bromo-2-nitro-trans-cinnamic acid 
• 861590-51-4 5-bromo-2-nitro-mandelonitrile 
• 38224-23-6 N-<5-Brom-2-nitro-benzyliden>-4-brom-anilin 
• 112768-03-3 (E)-3-(5-Bromo-2-nitro-phenyl)-2-(4-methoxy-phenyl)-acrylic acid 
• 112768-07-7 (Z)-3-(5-Bromo-2-nitro-phenyl)-2-(4-methoxy-phenyl)-acrylic acid 
• 796873-09-1 2-methyl-5-bromo-2H-indazole-N-oxide 
• 96330-26-6 2-(5-bromo-benzo[c]isoxazol-3-yl)-benzene-1,4-diol 
• 20357-31-7 5-bromo-2-nitro-cinnamic acid 
• 1356116-29-4 methyl 5-bromo-2-((methoxycarbonyl)amino)benzoate 

Relevant articles and documents

Friedlaender approach for the incorporation of 6-bromoquinoline into novel chelating ligands

Nitration of 3-bromobenzaldehyde followed by sodium dithionite reduction provides 5-bromo-2-aminobenzaldehyde, which undergoes the Friedlaender condensation with a variety of enolizable ketones to afford bidentate and tridentate 6-bromoquinoline derivativ

o-Nitrobenzyl photoremovable groups with fluorescence uncaging reporting properties

o-Nitrobenzyl (o-NB) derivatives are the most widely applied photoremovable groups for the study of dynamic biological processes. By introducing different substituents to the benzylic position we were able to generate a fluorescence signal upon irradiatio

Triazole derivative having HSP90 (Heat Shock Protein) inhibiting activity, as well as preparation method and application of triazole derivative

The invention discloses a triazole derivative having an HSP90 (Heat Shock Protein) inhibiting activity, as well as a preparation method and an application of the triazole derivative. Specifically, the invention relates to the triazole derivative having a structure as shown in a formula (I), a stereisomer of the triazole derivative and a pharmaceutically acceptable salt, wherein the definition of each substituent group in the formula (I) and the definition in a description are the same. The compound with a novel structure has the HSP90 inhibiting activity, can be used to cure cancers, neurodegenerative disorders, inflammation diseases, autoimmune diseases, ischemic brain injuries and the like, and has a broad application prospect.